These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1622701)

  • 1. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term effects of propafenone in ventricular arrhythmias.
    Gaita F; Richiardi E; Bocchiardo M; Asteggiano R; Pinnavaia A; Di Leo M; Rosettani E; Brusca A
    Int J Cardiol; 1986 Nov; 13(2):163-70. PubMed ID: 3793276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R; Skrabucha B; Kunicki PK; Kowalik I; Skorykow-Sapińska A; Sitkiewicz D; Sadowski Z
    Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
    Vincenti A; Landolina M; Latini R; Cavalli A; Gaita F; Giani P
    Am Heart J; 1992 Aug; 124(2):374-80. PubMed ID: 1636581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term study of propafenone in severe ventricular extrasystole in elderly subjects].
    Escande M; Diadema B; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1989 Nov; 38(9):555-60. PubMed ID: 2481423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V; Do Ngoc D; Fidelle J; Sidi D; Batisse A; Loth P; Vrancea F; Villain E; Coumel P
    Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1385-93. PubMed ID: 3122689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic ventricular arrhythmias with the new class Ic anti-arrhythmia agent diprafenon--results of long-term therapy].
    Heuer H; Gülker H; Hasfeld M; Frenking B; Behrenbeck T
    Z Kardiol; 1987 Jul; 76(7):415-20. PubMed ID: 3673163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and tolerance of propafenone in the treatment of cardiac rhythm disorders. Evaluation of a multicenter open trial on 3,687 patients].
    Clémenty J; Coste P; Metzinger M
    Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):207-12. PubMed ID: 3296928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy].
    Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F
    G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.